UK markets closed
NIKKEI 225
38,202.37 -632.73 (-1.63%) HANG SENG
18,313.86 -165.51 (-0.90%) CRUDE OIL
79.01 +0.63 (+0.80%) GOLD FUTURES
2,319.50 -4.70 (-0.20%) DOW
39,046.47 +162.21 (+0.42%) Bitcoin GBP
50,049.28 -351.09 (-0.70%)
Bio-Rad Laboratories, Inc. (BIO)
NYSE - Nasdaq Real-time price. Currency in USD
Add to watchlist
As of 02:39PM EDT. Market open.
| Previous close | 279.91 |
| Open | 272.52 |
| Bid | 269.43 x 900 |
| Ask | 270.28 x 3000 |
| Day's range | 268.27 - 279.15 |
| 52-week range | 261.59 - 431.79 |
| Volume | |
| Avg. volume | 215,124 |
| Market cap | 7.7B |
| Beta (5Y monthly) | N/A |
| PE ratio (TTM) | N/A |
| EPS (TTM) | -21.83 |
| Earnings date | 01 Aug 2024 - 05 Aug 2024 |
| Forward dividend & yield | N/A (N/A) |
| Ex-dividend date | N/A |
| 1y target est | 399.00 |
ZacksBio-Rad (BIO) Q1 Earnings Surpass Estimates, Margins Down
Bio-Rad's (BIO) Clinical Diagnostics arm registers growth in Q1, primarily driven by an increased demand for quality control, blood typing, and diabetes products.
Insider MonkeyBio-Rad Laboratories, Inc. (NYSE:BIO) Q1 2024 Earnings Call Transcript
Bio-Rad Laboratories, Inc. (NYSE:BIO) Q1 2024 Earnings Call Transcript May 7, 2024 Bio-Rad Laboratories, Inc. isn’t one of the 30 most popular stocks among hedge funds at the end of the third quarter (see the details here). Operator: Good afternoon everyone, and welcome to today’s Bio-Rad First Quarter 2024 Earnings Results Conference Call. At this […]
- Thomson Reuters StreetEvents
Q1 2024 Bio Rad Laboratories Inc Earnings Call
Q1 2024 Bio Rad Laboratories Inc Earnings Call
© 2024 Yahoo. All rights reserved.